The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD+ cells via RUNX1Seiji Fukuda(Sugiyama Jogakuen University), Louis M. Pelus(Maryland Oncology Hematology)Leukemia ResearchOctober 29, 202210.1016/j.leukres.2022.106983Cited by 4SaveCiteExport RISWatch citationsRelated PapersCXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation|Stem Cells|2020|65